2025
SJR Q2
JCR Q2 · 2,9
67 matched articles
SCIE
Journal detail
Microvascular Research
- Publisher
- Academic Press Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0026286210959319
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,772
- Quartile Q2
- H-Index 105
- Cites/doc 3,13
- Docs (3y) 336
- Cites (3y) 987
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 3
- JCI 0,68
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Cardiology and Cardiovascular Medicine Q2
- Cell Biology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,772 | 2,9 | 3 | 0,68 | Q2 | 105 |
| 2024 | Q2 | Q2 | 0,78 | 2,7 | 3 | 0,76 | Q2 | 103 |
| 2023 | Q2 | Q2 | 0,731 | 2,9 | 3 | 0,76 | Q2 | 103 |
| 2022 | Q2 | Q2 | 0,74 | 3,1 | 2,9 | 0,74 | Q2 | 103 |
| 2021 | Q2 | Q2 | 0,682 | 3,8 | 3,4 | 0,75 | Q2 | 103 |
| 2020 | Q2 | Q2 | 0,819 | 3,5 | 3,1 | 0,82 | Q2 | 103 |
| 2019 | Q2 | Q2 | 0,709 | 2,7 | 2,4 | 0,79 | Q1 | 103 |
| 2018 | — | Q2 | — | 2,6 | 2,6 | 0,75 | Q2 | — |
| 2017 | Q2 | Q3 | 0,974 | 2,5 | 2,5 | 0,65 | Q2 | 103 |
| 2016 | Q2 | Q3 | 0,992 | 2,4 | 2,3 | — | — | 103 |
| 2015 | Q1 | Q3 | 1,054 | 2,3 | 2,6 | — | — | 103 |
| 2014 | Q2 | Q3 | 0,967 | 2,1 | 2,6 | — | — | 103 |
| 2013 | Q1 | Q3 | 1,107 | 2,4 | 2,9 | — | — | 103 |
| 2012 | Q1 | Q2 | 1,106 | 2,9 | 3 | — | — | 103 |
| 2011 | Q1 | Q2 | 1,302 | 2,8 | 3 | — | — | 103 |
| 2010 | Q1 | Q2 | 1,179 | 2,4 | 2,6 | — | — | 103 |
| 2009 | — | Q2 | — | 3,1 | 3,1 | — | — | — |
| 2008 | — | Q2 | — | 3 | 2,8 | — | — | — |
| 2007 | — | Q2 | — | 2,4 | 2,5 | — | — | — |
| 2006 | — | Q2 | — | 2,5 | — | — | — | — |
| 2005 | — | Q2 | — | 2,4 | — | — | — | — |
| 2004 | — | Q2 | — | 2,4 | — | — | — | — |
| 2003 | — | Q2 | — | 1,9 | — | — | — | — |
| 2002 | — | Q2 | — | 1,5 | — | — | — | — |
| 2001 | — | Q3 | — | 1,5 | — | — | — | — |
| 2000 | — | Q2 | — | 2 | — | — | — | — |
| 1999 | — | Q2 | — | 1,7 | — | — | — | — |
| 1998 | — | Q2 | — | 1,5 | — | — | — | — |
| 1997 | — | Q2 | — | 1,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 43/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 41/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 30/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 31/68 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 30/67 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 27/65 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 29/65 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 32/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 37/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 39/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 41/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 29/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/56 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 25/54 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/52 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/51 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/51 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/52 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 28/50 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/45 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/44 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/39 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/38 |